FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

James Kalus

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Devices

Defibrillators, Implantable

Co-author Network

Publications

TOP 3
James Kalus
Pharmacologic interventions for reversing the effects of oral anticoagulants.
Stephanie B Edwin; Douglas L Jennings; James Kalus
An evaluation of the early pharmacodynamic response after simultaneous initiation of warfarin and amiodarone.
James Kalus
Pharmacotherapeutic decision-making for patients with atrial fibrillation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of James Kalus (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: James Kalus
Pharmacologic interventions for reversing the effects of oral anticoagulants.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2013;70(10 Suppl 1):S12-21.
2010: Stephanie B Edwin; Douglas L Jennings; James Kalus
An evaluation of the early pharmacodynamic response after simultaneous initiation of warfarin and amiodarone.
Journal of clinical pharmacology 2010;50(6):693-8.
2010: James Kalus
Pharmacotherapeutic decision-making for patients with atrial fibrillation.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2010;67(9 Suppl 5):S17-25.
2010: Douglas L Jennings; James Kalus
Addition of cilostazol to aspirin and a thienopyridine for prevention of restenosis after coronary artery stenting: a meta-analysis.
Journal of clinical pharmacology 2010;50(4):415-21.
2009: Leah Steinke; David E Lanfear; Vishnuprabha Dhanapal; James Kalus
Effect of "energy drink" consumption on hemodynamic and electrocardiographic parameters in healthy young adults.
The Annals of pharmacotherapy 2009;43(4):596-602.
2008: Brian F McBride; C Michael White; James Kalus; Danette Guertin; Christopher A Clyne; William L Baker; Jeffrey Kluger
The impact of carvedilol on the defibrillation threshold.
Heart & lung : the journal of critical care 2008;37(1):67-71.
2007: Brian F Mc Bride; James Kalus; Danette Guertin; Krista M Dale; Jeffrey Kluger; C Michael White
Impact of catecholamines on the QTc interval in patients at high risk of sudden death.
Connecticut medicine 2007;71(8):465-8.
2007: Rosemarie Fernandez; Dennis Parker; James Kalus; Douglas Miller; Scott Compton
Using a human patient simulation mannequin to teach interdisciplinary team skills to pharmacy students.
American journal of pharmaceutical education 2007;71(3):51.
2007: D L Jennings; James Kalus; Craig I Coleman; C Manierski; Jerry Yee
Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis.
Diabetic medicine : a journal of the British Diabetic Association 2007;24(5):486-93.
2007: Helen Doreen Berlie; James Kalus; Linda A Jaber
Thiazolidinediones and the risk of edema: a meta-analysis.
Diabetes research and clinical practice 2007;76(2):279-89.
2007: Megan L Winegardner; Kristen T Reaume; Gladys S Dabaja; James Kalus
Practical application of nonrandomized research to patient care: a case study of nesiritide.
Pharmacotherapy 2007;27(1):143-51.
2006: Patricia A Howard; Judy W M Cheng; Michael A Crouch; Vincent J Colucci; James Kalus; Sarah A Spinler; Mark A Munger
Drug therapy recommendations from the 2005 ACC/AHA guidelines for treatment of chronic heart failure.
The Annals of pharmacotherapy 2006;40(9):1607-17.
2006: Douglas L Jennings; Jill C Petricca; Leah A Yageman; Kate M O'Dell; James Kalus
Predictors of rehospitalization after acute coronary syndromes.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2006;63(4):367-72.
2006: James Kalus; Craig I Coleman; C Michael White
The impact of suppressing the renin-angiotensin system on atrial fibrillation.
Journal of clinical pharmacology 2006;46(1):21-8.
2005: James Kalus; C Michael White; Michael F Caron; Danette Guertin; Brian F McBride; Jeffrey Kluger
The impact of catecholamines on defibrillation threshold in patients with implanted cardioverter defibrillators.
Pacing and clinical electrophysiology : PACE 2005;28(11):1147-56.
2005: Douglas L Jennings; James Kalus; Kate M O'Dell
Aldosterone receptor antagonism in heart failure.
Pharmacotherapy 2005;25(8):1126-33.
2005: Bokyung Min; Jeffrey Kluger; James Kalus; Danette Guertin; Brian F McBride; C Michael White
The impact of catecholamines in patients with or without beta-blockers on the ventricular fibrillation cycle length and ventricular fibrillation cycle length variability.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2005;10(3):305-11.
2005: John E Madias; Jessica Song; C Michael White; James Kalus; Jeffrey Kluger
Response of the ECG to short-term diuresis in patients with heart failure.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2005;10(3):288-96.
2005: Kate M O'Dell; James Kalus; Suzan N Kucukarslan; Barbara Czerska
Nesiritide for secondary pulmonary hypertension in patients with end-stage heart failure.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2005;62(6):606-9.
2005: James Kalus; Lynette R Moser
Evolving role of low-molecular-weight heparins in ST-elevation myocardial infarction.
The Annals of pharmacotherapy 2005;39(3):481-91.
2005: James Kalus
Correction: Role of low-molecular-weight heparin in invasive management of non-ST-elevation acute coronary syndromes.
The Annals of pharmacotherapy 2005;39(1):201.
2004: James Kalus; Michael F Caron; C Michael White; Jeffrey F Mather; Robert Gallagher; William E Boden; Jeffrey Kluger
Impact of fluid balance on incidence of atrial fibrillation after cardiothoracic surgery.
The American journal of cardiology 2004;94(11):1423-5.
2004: Lynette R Moser; James Kalus
Role of low-molecular-weight heparin in invasive management of non-ST-elevation acute coronary syndromes.
The Annals of pharmacotherapy 2004;38(12):2094-104.
2004: Prabashni Reddy; James Kalus; Michael F Caron; Sheryl Horowitz; Angiliki Karapanos; Craig I Coleman; Jeffrey Kluger; C Michael White
Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgery.
Pharmacotherapy 2004;24(8):1013-9.
2004: Alexandria A Piotrowski; James Kalus
Magnesium for the treatment and prevention of atrial tachyarrhythmias.
Pharmacotherapy 2004;24(7):879-95.
2004: James Kalus; Michael F Caron
Novel uses for current and future direct thrombin inhibitors: focus on ximelagatran and bivalirudin.
Expert opinion on investigational drugs 2004;13(5):465-77.
2004: Seth T Cioffi; Michael F Caron; James Kalus; Patricia Hill; Thomas E Buckley
Glycosylated hemoglobin, cardiovascular, and renal outcomes in a pharmacist-managed clinic.
The Annals of pharmacotherapy 2004;38(5):771-5.
2004: James Kalus; Jeffrey Kluger; Michael F Caron; Xinhcun Liu; Chester Humphrey; C Michael White
An evaluation of postoperative P-wave variables after cardiothoracic surgery.
Journal of electrocardiology 2004;37(2):127-32.
2004: Craig I Coleman; James Kalus; Michael F Caron; Jeffrey Kluger; C Michael White
Model of effect of magnesium prophylaxis on frequency of torsades de pointes in ibutilide-treated patients.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2004;61(7):685-8.
2004: James Kalus; C Michael White; Michael F Caron; Craig I Coleman; Hiroyoshi Takata; Jeffrey Kluger
Indicators of atrial fibrillation risk in cardiac surgery patients on prophylactic amiodarone.
The Annals of thoracic surgery 2004;77(4):1288-92.
2004: Craig I Coleman; James Kalus; C Michael White; Anne P Spencer; James P Tsikouris; Jenny O Chung; Kenneth W Kenyon; Martin Ziska; Jeffrey Kluger; Prabashni Reddy
Cost effectiveness of ibutilide with prophylactic magnesium in the treatment of atrial fibrillation.
PharmacoEconomics 2004;22(13):877-83.
2003: James Kalus; Anne P Spencer; James P Tsikouris; Jenny O Chung; Kenneth W Kenyon; Martin Ziska; Jeffrey Kluger; C Michael White
Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2003;60(22):2308-12.
2003: C Michael White; Michael F Caron; James Kalus; Heidi Rose; Jessica Song; Prabashni Reddy; Robert Gallagher; Jeffrey Kluger
Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II (AFIST II).
Circulation 2003;108 Suppl 1():II200-6.
2003: James Kalus; Alexandria A Piotrowski; Christopher R Fortier; Xinhcun Liu; Jeffrey Kluger; C Michael White
Hemodynamic and electrocardiographic effects of short-term Ginkgo biloba.
The Annals of pharmacotherapy 2003;37(3):345-9.
2003: Michael F Caron; Jeffrey Kluger; James P Tsikouris; Arnold Ritvo; James Kalus; C Michael White
Effects of intravenous magnesium sulfate on the QT interval in patients receiving ibutilide.
Pharmacotherapy 2003;23(3):296-300.
2002: James Kalus; C Michael White
Monitoring antifactor Xa activity of the low-molecular-weight heparins in the clinical setting: who, why, how, and when?
Connecticut medicine 2002;66(12):749-52.
2002: C Michael White; James Kalus; Robert A Quercia; Christopher Fortier; Alexandria Piotrowski; Albert Roach; Mark B Sostek
Delivery of esomeprazole magnesium enteric-coated pellets through small caliber and standard nasogastric tubes and gastrostomy tubes in vitro.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2002;59(21):2085-8.
2002: James Kalus; C Michael White
Amlodipine versus Angiotensin-receptor blockers for nonhypertension indications.
The Annals of pharmacotherapy 2002;36(11):1759-66.
2002: Jawad Haider; James Kalus; C Michael White; Dhiraj D Narula; Danette Guertin; Michael F Caron; Jeffrey Kluger
The effect of head-upright tilt table testing for vasovagal syncope on P-wave duration.
Journal of electrocardiology 2002;35(4):303-6.
2002: Jessica Song; James Kalus; Michael F Caron; Jeffrey Kluger; C Michael White
Effect of diuresis on P-wave duration and dispersion.
Pharmacotherapy 2002;22(5):564-8.
2002: James Kalus; Jean M Nappi
Role of race in the pharmacotherapy of heart failure.
The Annals of pharmacotherapy 2002;36(3):471-8.
2001: James Kalus; C Michael White
A comprehensive review of antihypertensive agents providing renal protection.
Connecticut medicine 2001;65(10):587-91.
2001: James Kalus; Anne P Spencer
Enoxaparin should be used cautiously in patients with end-stage renal disease.
Pharmacotherapy 2001;21(8):1015-6; author reply 1017-9.
2001: James Kalus; C A Lober
Calcium-channel antagonists and nitrates in coronary artery bypass patients receiving radial artery grafts.
The Annals of pharmacotherapy 2001;35(5):631-5.
2000: James Kalus; Vincent F Mauro
Dofetilide: a class III-specific antiarrhythmic agent.
The Annals of pharmacotherapy 2000;34(1):44-56.